NM_005592.4:c.1239G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005592.4(MUSK):​c.1239G>A​(p.Met413Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.128 in 1,613,518 control chromosomes in the GnomAD database, including 14,411 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M413T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.099 ( 963 hom., cov: 32)
Exomes 𝑓: 0.13 ( 13448 hom. )

Consequence

MUSK
NM_005592.4 missense

Scores

1
1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.872

Publications

25 publications found
Variant links:
Genes affected
MUSK (HGNC:7525): (muscle associated receptor tyrosine kinase) This gene encodes a muscle-specific tyrosine kinase receptor. The encoded protein may play a role in clustering of the acetylcholine receptor in the postsynaptic neuromuscular junction. Mutations in this gene have been associated with congenital myasthenic syndrome. Alternatively spliced transcript variants have been described.[provided by RefSeq, Oct 2009]
MUSK Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 9
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • fetal akinesia deformation sequence 1
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0040370524).
BP6
Variant 9-110775842-G-A is Benign according to our data. Variant chr9-110775842-G-A is described in ClinVar as Benign. ClinVar VariationId is 129630.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.191 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MUSKNM_005592.4 linkc.1239G>A p.Met413Ile missense_variant Exon 10 of 15 ENST00000374448.9 NP_005583.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MUSKENST00000374448.9 linkc.1239G>A p.Met413Ile missense_variant Exon 10 of 15 5 NM_005592.4 ENSP00000363571.4
MUSKENST00000416899.7 linkc.1239G>A p.Met413Ile missense_variant Exon 10 of 14 5 ENSP00000393608.3
MUSKENST00000189978.10 linkc.1005G>A p.Met335Ile missense_variant Exon 10 of 14 5 ENSP00000189978.6
MUSKENST00000374438.1 linkn.496G>A non_coding_transcript_exon_variant Exon 1 of 3 3

Frequencies

GnomAD3 genomes
AF:
0.0988
AC:
15021
AN:
151960
Hom.:
964
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0223
Gnomad AMI
AF:
0.163
Gnomad AMR
AF:
0.0551
Gnomad ASJ
AF:
0.103
Gnomad EAS
AF:
0.201
Gnomad SAS
AF:
0.147
Gnomad FIN
AF:
0.156
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.135
Gnomad OTH
AF:
0.0705
GnomAD2 exomes
AF:
0.120
AC:
29807
AN:
249200
AF XY:
0.124
show subpopulations
Gnomad AFR exome
AF:
0.0197
Gnomad AMR exome
AF:
0.0403
Gnomad ASJ exome
AF:
0.0978
Gnomad EAS exome
AF:
0.196
Gnomad FIN exome
AF:
0.158
Gnomad NFE exome
AF:
0.133
Gnomad OTH exome
AF:
0.107
GnomAD4 exome
AF:
0.132
AC:
192302
AN:
1461440
Hom.:
13448
Cov.:
32
AF XY:
0.133
AC XY:
96646
AN XY:
727022
show subpopulations
African (AFR)
AF:
0.0172
AC:
577
AN:
33476
American (AMR)
AF:
0.0413
AC:
1846
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.100
AC:
2622
AN:
26132
East Asian (EAS)
AF:
0.224
AC:
8878
AN:
39694
South Asian (SAS)
AF:
0.148
AC:
12732
AN:
86256
European-Finnish (FIN)
AF:
0.158
AC:
8439
AN:
53398
Middle Eastern (MID)
AF:
0.0570
AC:
329
AN:
5768
European-Non Finnish (NFE)
AF:
0.135
AC:
150152
AN:
1111628
Other (OTH)
AF:
0.111
AC:
6727
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
8520
17040
25560
34080
42600
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5368
10736
16104
21472
26840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0988
AC:
15020
AN:
152078
Hom.:
963
Cov.:
32
AF XY:
0.100
AC XY:
7443
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.0223
AC:
925
AN:
41516
American (AMR)
AF:
0.0550
AC:
841
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.103
AC:
356
AN:
3468
East Asian (EAS)
AF:
0.201
AC:
1039
AN:
5160
South Asian (SAS)
AF:
0.148
AC:
710
AN:
4810
European-Finnish (FIN)
AF:
0.156
AC:
1650
AN:
10564
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.135
AC:
9191
AN:
67962
Other (OTH)
AF:
0.0707
AC:
149
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
681
1363
2044
2726
3407
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
186
372
558
744
930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.116
Hom.:
2562
Bravo
AF:
0.0861
TwinsUK
AF:
0.135
AC:
501
ALSPAC
AF:
0.137
AC:
527
ESP6500AA
AF:
0.0219
AC:
83
ESP6500EA
AF:
0.133
AC:
1094
ExAC
AF:
0.121
AC:
14602
Asia WGS
AF:
0.162
AC:
562
AN:
3478
EpiCase
AF:
0.127
EpiControl
AF:
0.120

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
May 20, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Fetal akinesia deformation sequence 1;C4225368:Congenital myasthenic syndrome 9 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital myasthenic syndrome 9 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.62
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
16
DANN
Benign
0.91
DEOGEN2
Benign
0.075
T;.;.;.
Eigen
Benign
-0.61
Eigen_PC
Benign
-0.47
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.85
T;T;D;D
MetaRNN
Benign
0.0040
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.88
L;.;.;.
PhyloP100
0.87
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.18
N;.;.;.
REVEL
Benign
0.063
Sift
Benign
0.60
T;.;.;.
Sift4G
Benign
0.50
T;T;T;T
Polyphen
0.0
B;.;.;.
Vest4
0.048
MutPred
0.48
Gain of methylation at K416 (P = 0.0832);Gain of methylation at K416 (P = 0.0832);.;.;
MPC
0.18
ClinPred
0.0050
T
GERP RS
1.1
Varity_R
0.052
gMVP
0.23
Mutation Taster
=81/19
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2274419; hg19: chr9-113538122; COSMIC: COSV51886200; API